Select therapeutic use:
Indications for ELIPHOS:
Hyperphosphatemia in end stage renal failure.
Initially 2 tabs with each meal; may adjust dose to keep serum phosphate <6mg/dL. Usual dose: 3–4 tabs per meal.
Monitor serum calcium twice weekly during early dose adjustments, and serum phosphorus periodically. Ensure serum (Ca x P) to remain <66. Pregnancy (Cat.C).
Avoid digitalis, calcium supplements, antacids. May antagonize tetracyclines.